Mentor: Dawn Quelle, PhD

Research:

My research investigates the tumor microenvironment of rare cancers, specifically malignant peripheral nerve sheath tumors (MPNST) and neuroendocrine tumors (NET), to discover druggable vulnerabilities.

Publications:

Mishra T, Edwards A, Wu L. Pharmacological METTL3 inhibition attenuates HIV-1 latency reversal in CD4+ T cells. Antimicrob Agents Chemother. 2026 Jul;70(7):e0040026. doi: 10.1128/aac.00400-26. Epub 2026 May 29. PMID: 42210692; PMCID: PMC13321796.

Awards:

Predoctoral Training Grant in the Pharmacological Sciences (T32 GM144636), 2026-present